Results 251 to 260 of about 186,280 (306)

Cross‐Cohort Evidence Links KCNJ6 rs702859 to Impulsive–Compulsive Phenotypes in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Impulse control disorders (ICDs) and related compulsive behaviors (CBs) are frequent non‐motor complications of Parkinson's disease (PD) with a probable genetic contribution. Objective To investigate whether genetic variants involved in reward and punishment processing are associated with impulsive–compulsive phenotypes in PD ...
Sergio García‐Díaz   +21 more
wiley   +1 more source

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)‐VK4‐116, as a Non‐Opioid Medication for the Treatment of Opioid Use Disorder

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu   +15 more
wiley   +1 more source

Characterizing trends and patterns in benzodiazepine-related toxicity deaths in Ontario: A descriptive cross-sectional study. [PDF]

open access: yesPLoS One
Campbell T   +11 more
europepmc   +1 more source

Medicine Use Preceding Fatal Poisonings Among Individuals With Bipolar Disorder. [PDF]

open access: yesBasic Clin Pharmacol Toxicol
Salmelainen J   +6 more
europepmc   +1 more source

National trends in naloxone codispensing with outpatient opioid prescriptions, 2013-2023. [PDF]

open access: yesReg Anesth Pain Med
Beck EJ   +6 more
europepmc   +1 more source

Impact of treatment duration on the effectiveness of opioid analgesia: a systematic review and meta-analysis. [PDF]

open access: yesBr J Gen Pract
Froentjes LS   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy